Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$27.1M
+10.8% from 2023
Prescriptions
48K
$567.40 per claim
Patients
13K
6,598 prescribers
Total spending, 2024
$27.1M
$2,062.03 per patient
Medicare prescription drug plans paid $27.1M for Retacrit in 2024, for 47,802 prescriptions and refills to 13,152 patients (up 10.8% from 2023). The average cost per claim was $567.40.
New York had the highest Medicare cost for Retacrit in 2024: $5.4M for 9,204 claims, followed by Florida ($3.7M).
Eddiemar Ortiz Cruz, hematology-oncology in San Juan, PR, had the highest Medicare cost for Retacrit in 2024: 81 claims costing $388K.
Retacrit is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eddiemar Ortiz Cruz San Juan, PR | Hematology-Oncology | 81 | 55 | $388K |
| Wei Y Sun New York, NY | Nephrology | 560 | 127 | $289K |
| Elizabeth Liang Flushing, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 7,109 | 55,583 | 14,370 | $32.9M |
| 2023 | 6,259 | 41,943 | 12,160 | $24.5M |
| 2024 | 6,598 | 47,802 | 13,152 | $27.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nephrology |
| 255 |
| 72 |
| $197K |
| Syed S Rafique Greenwood, MS | Hematology-Oncology | 110 | 20 | $181K |
| M Ashraf Meelu Waldorf, MD | Hematology-Oncology | 89 | 28 | $175K |
| Syed H Abid St Petersburg, FL | Medical Oncology | 115 | 49 | $165K |
| Gopal R Kunta Clermont, FL | Medical Oncology | 95 | 31 | $155K |
| Pratibha K Desai Saint Petersburg, FL | Hematology-Oncology | 103 | 40 | $143K |
| Thomas J Katta Orlando, FL | Hematology-Oncology | 128 | 24 | $142K |
| Li Yang Brooklyn, NY | Nephrology | 237 | 41 | $133K |
| Andrew M Schneider Tamarac, FL | Hematology-Oncology | 109 | 42 | $124K |
| Monica Mendez Ayala Manati, PR | Hematology-Oncology | 47 | 32 | $124K |
| Graciany Miranda Humacao, PR | Hematology-Oncology | 118 | 63 | $123K |
| Erick G Cruz Mayaguez, PR | Hematology-Oncology | 68 | 51 | $120K |
| John C Hughes Saginaw, MI | Hematology-Oncology | 80 | Under 11 | $119K |
| Luis A Figueroa Canovanas, PR | Hematology-Oncology | 43 | 33 | $107K |
| Chintan C Gandhi Tamarac, FL | Hematology-Oncology | 88 | 33 | $99K |
| Kalpesh B Barot Orlando, FL | Hematology-Oncology | 111 | 24 | $95K |
| Sudhir Hansalia Trinity, FL | Hematology-Oncology | 81 | 19 | $89K |
| Alec S Goldenberg New York, NY | Hematology-Oncology | 44 | Under 11 | $88K |
| Muhammad I Kafeel Richmond Hill, NY | Hematology-Oncology | 69 | 23 | $86K |
| William Cheung New York, NY | Internal Medicine | 139 | 35 | $84K |
| Christian Rolon Mayaguez, PR | Hematology-Oncology | 75 | 33 | $83K |
| Luis A Cotto Santana San Juan, PR | Hematology-Oncology | 47 | 28 | $82K |
| Rafael D Betancourt Garcia Guaynabo, PR | Hematology-Oncology | 48 | 34 | $82K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 47,809 | $27.1M |